Soy Protein-fed Rats Research Articles

Dietary soy, meat, and fish proteins modulate the effects of prebiotic raffinose on composition and fermentation of gut microbiota in rats

Soy, meat (mixture of pork and beef), and fish proteins were fed to rats with and without prebiotic raffinose (RAF), and the composition and fermentation of gut microbiota were examined. Bifidobacterium spp. populations were higher, and propionic acid concentration was lower in soy protein-fed than meat protein-fed rats. Likewise, Enterobacteriaceae populations were higher in fish protein-fed rats than other rats. RAF feeding increased Bifidobacterium spp. and decreased Faecalibacterium prausnitzii populations regardless of the dietary protein source. Interactions between dietary proteins and RAF were shown for Lactobacillus spp. and Clostridium perfringens group; the increase of Lactobacillus spp. populations by RAF was seen only for soy protein-fed rats, whereas the reduction of C. perfringens group by RAF was evident in fish and meat protein-fed rats. It is concluded that dietary proteins may differentially modulate the effects of prebiotic oligosaccharides on gut fermentation and microbiota, with differences observed between plant and animal proteins.

Dietary soy protein induces hepatic lipogenic enzyme gene expression while suppressing hepatosteatosis in obese female Zucker rats bearing DMBA-initiated mammary tumors

Fatty liver is associated with obesity and breast cancer. We used an obese rat model of mammary cancer to examine whether hepatosteatosis is modifiable by diet and associated with altered expression of hepatic lipogenic enzyme genes, thyroid hormone system genes and cholesterol metabolism-related genes. Beginning at the age of 5weeks, lean and obese female Zucker rats were fed high-isoflavone soy protein- or casein (control protein)-containing diets. Rats were euthanized at 200days of age [corresponding to 147days after administration of carcinogen to induce mammary tumors; (Hakkak et al. in, Oncol Lett 2:29-36, 2011)]. Obese rats had a greater degree of liver steatosis than lean rats. Obese casein-fed rats had marked steatosis with small foci of mononuclear infiltration, whereas obese soy protein-fed rats had a significantly lower steatosis index. Comparisons between lean and obese casein-fed rats showed that obesity was associated with significant reductions in hepatic mRNA abundance for Glucose 6-Phosphate Dehydrogenase (G6PD), 6-Phosphogluconate Dehydrogenase (6PGD), Thyroid Receptor Alpha 1 (TRα1), Thyroid Receptor Beta 1 (TRβ1) and Iodothyronine Deiodinase 1 (DIO1). The soy protein diet was associated with increased expression of Fatty Acid Synthase (FASN), Malic Enzyme 1 (ME1), 6PGD, Sterol Regulatory Element Binding Protein-1c (SREBP-1c) and SREBP-2 genes in the livers of obese but not lean rats. Western blot analysis showed a significant induction of ME1 protein expression in the livers of obese, soy protein-fed rats, which paralleled the increased serum insulin level in this group. Long-term soy protein consumption can counter hepatic steatosis while coincidently promoting hepatic lipogenic gene expression, the latter likely a consequence of elevated serum insulin. We suggest that elevations in serum insulin, hepatic lipogenesis and cholesterol synthesis all contributed to the increased tumorigenesis previously observed for the obese, soy protein-fed rats.

Soy protein supports cardiovascular health by downregulating hydroxymethylglutaryl–coenzyme A reductase and sterol regulatory element-binding protein–2 and increasing antioxidant enzyme activity in rats with dextran sodium sulfate–induced mild systemic inflammation

Animal and human studies have indicated that the presence of soy in the diet improves cardiovascular health. Inflammation plays a pivotal role in the progression of cardiovascular disease (CVD). However, little is known about how dextran sodium sulfate (DSS)-induced systemic inflammation impacts overall heart health and, correspondingly, how soy protein modulates risk of CVD development in DSS-induced systemic inflammation. We hypothesized that soy protein-fed rats would have a lower risk of CVD by beneficial alteration of gene expression involving lipid metabolism and antioxidant capacity in DSS-induced systemic inflammation. Forty Sprague-Dawley rats were divided into 4 groups: casein, casein + DSS, soy protein, and soy protein + DSS. After 26 days, inflammation was induced in one group from each diet by incorporating 3% DSS in drinking water for 48 hours. Soy protein-fed rats had lower final body weights (P = .010), epididymal fat weights (P = .049), total cholesterol (P < .001), and low-density lipoprotein cholesterol (P < .001). In regard to gene expression, soy protein-fed rats had lower sterol regulatory element-binding protein-2 (P = .032) and hydroxymethylglutaryl-coenzyme A reductase (P = .028) levels and higher low-density lipoprotein receptor levels (P = .036). Antioxidant enzyme activity of superoxide dismutase and catalase was higher among the soy protein groups (P = .037 and P = .002, respectively). These results suggest that soy protein positively influences cardiovascular health by regulating serum lipids through modified expression of sterol regulatory element-binding protein-2 and its downstream genes (ie, hydroxymethylglutaryl-coenzyme A reductase and low-density lipoprotein receptor) and by promoting the antioxidant enzyme activity of superoxide dismutase and catalase.

Soy Protein and Fish Oil Independently Decrease Serum Lipid Concentrations but Interactively Reduce Hepatic Enzymatic Activity and Gene Expression Involved in Fatty Acid Synthesis in Rats

The degree of interaction between dietary protein and fat sources to modulate hepatic lipid metabolism was investigated. Male rats were fed diets containing either casein or soy protein isolate as the protein source and either palm or soy oil as the fat source. After 3 wk, the activity and mRNA expression of enzymes involved in hepatic fatty acid synthesis were significantly lower with soy protein than casein when palm oil was the fat source. The same values for the same enzymes were greatly lowered regardless of the protein source when fish oil was the fat source. Both enzymatic activity and mRNA expression for fatty acid oxidation were significantly stimulated by fish oil, but only the former was increased by soy protein. Although both soy protein and fish oil reduced serum lipid concentrations, they worked independently. In soy protein-fed rats, mRNA levels of key enzymes related to cholesterol and bile acid synthesis were decreased and increased, respectively, compared with levels in casein-fed animals. Instead, fish oil strongly induced the mRNA expression of biliary cholesterol transporters, ATP-binding cassette sub-family G, member 5 (ABCG5) and ATP-binding cassette sub-family G, member 8 (ABCG8). Therefore, dietary soy protein and fish oil generally exerted independent hypolipidemic actions in rats. However, the reduction of hepatic fatty acid synthesis caused by the simultaneous ingestion of soy protein and fish oil was smaller than their expected additive reduction, because fish oil strongly decreased the synthesis.

Soy protein influences plasma lipid profiles but does not reduce interleukin‐6 inflammation marker in dextran sodium sulfate treated rats

Clinical and experimental data have indicated that soybeans, soybean constituents and soy isoflavones have health implications in preventing cardiovascular disease (CVD). Inflammation and serum lipid profiles play pivotal roles in the development of CVD. We investigated the role of soy protein on lipid profiles, and inflammation indicated by the interleukin‐6 (IL‐6) level in 3% dextran sodium sulfate (DSS)‐treated rats. The soy protein isolate used in the study contained 825 μg, 485 μg and 181 μg of genistein, daidzein and glycitein per gram of soy protein isolate, respectively. Soy protein decreased total cholesterol (P&lt;0.001) and LDL‐cholesterol (P&lt;0.001) compared to casein. DSS treatment increased serum IL‐6 levels (P&lt;0.05) but IL‐6 levels were not significantly different between the diet groups. Interestingly, soy protein‐fed rats had lower final body weights (P&lt;0.05), along with lower liver (P&lt;0.01) and epididymal fat weights (P&lt;0.05) despite no differences in food intakes. These results demonstrate that soy protein isolate may lower the risk of CVD by improving serum lipid levels and lowering body weights. Further study is warranted to examine the mechanism of soy protein in body weight reduction and/or alteration of body composition. This study was supported in the Advanced Nutrition Lab at San Diego State University and funded by SDSU UGP and CHNR08‐810.

Effect of soy protein supplementation on the nutritive value of ‘gari’ (farina) from Manihot esculenta

The supplementary role of soy protein on cassava ( Manihot esculenta ) “gari” or farina was studied in 35 day-old albino rats of the Wistar strain ( n =6 per group) for 10 days. Gari was supplemented with soy beans at 10 and 15% soy protein levels to produce “soy gari” and the performances of rats fed the test diets compared with those on a 10% casein diet. Protein efficiency ratio (PER), Net protein utilization (NPU), true digestibility (TD) and biological values (BV) were the parameters used to assess the nutritional performance of the diets based on weight gains and nitrogen balance. The PER for 10% casein, 10 and 15% soy protein-supplemented gari groups were 2.31, 1.85 and 1.94 respectively, while the corresponding values for NPU were 71.9, 65.8 and 64.1, respectively. The TD values for the 10% casein, 10 and 15% soy protein-fed rats were 97.2, 91.9 and 90.0, respectively, while the corresponding values for BV were 73.9, 70.9 and 71.5. The PER, NPU, TD and BV for 10% casein diet were significantly superior ( P <0.05) to those of the soy gari diets which gave NPU, TD and BV values 89–97% of those of the casein diet. There were no significant differences ( P >0.05) in these parameters between the 10 and 15% soy protein supplementation. Soy gari is safe to the consumer, because the procedures involved in processing soy beans and cassava ensure the elimination of toxic anti-nutritional factors known to impact negatively on nutrient availability, metabolic processes and growth. It is suggested that the consumption of soy gari at 10% soy protein supplementation be promoted in gari-eating areas, to ameliorate the endemic problems of protein deficiency disorders.

Prevention of skeletal muscle insulin resistance by dietary cod protein in high fat-fed rats.

In the present study, we tested the hypothesis that fish protein may represent a key constituent of fish with glucoregulatory activity. Three groups of rats were fed a high-fat diet in which the protein source was casein, fish (cod) protein, or soy protein; these groups were compared with a group of chow-fed controls. High-fat feeding led to severe whole body and skeletal muscle insulin resistance in casein- or soy protein-fed rats, as assessed by the euglycemic clamp technique coupled with measurements of 2-deoxy-D-[(3)H]glucose uptake rates by individual tissues. However, feeding cod protein fully prevented the development of insulin resistance in high fat-fed rats. These animals exhibited higher rates of insulin-mediated muscle glucose disposal that were comparable to those of chow-fed rats. The beneficial effects of cod protein occurred without any reductions in body weight gain, adipose tissue accretion, or expression of tumor necrosis factor-alpha in fat and muscle. Moreover, L6 myocytes exposed to cod protein-derived amino acids showed greater rates of insulin-stimulated glucose uptake compared with cells incubated with casein- or soy protein-derived amino acids. These data demonstrate that feeding cod protein prevents obesity-induced muscle insulin resistance in high fat-fed obese rats at least in part through a direct action of amino acids on insulin-stimulated glucose uptake in skeletal muscle cells.

Casein, red meat and soyprotein effects on nutrient digestibility and the colonic microstructure of the laboratory rat

Fifty white male rats were used to study the effects of varied protein source (i.e. casein, red meat or soyprotein) on the development and morphology of the rat's gastrointestinal tract. Laboratory rats appeared to take well to the meat base diet, consuming more of that diet during the early days of the study. There were, however, apparent diet adaptation periods for all experimental diets. After 15 days on the diets, rats fed the soyprotein had heavier stomach weights, and less colonic weight than the casein or meat-fed rats. Colonic morphology studies indicated the meat-fed rats had greater width of colonic crypts, and a lower surface area to mucosal volume ratio than casein or soyprotein-fed rats.

54Mn absorption and excretion in rats fed soy protein and casein diets.

Rats were fed diets containing either soy protein or casein and different levels of manganese, methionine, phytic acid, or arginine for 7 days and then fed test meals labeled with 2 microCi of 54Mn after an overnight fast. Retention of 54Mn in each rat was measured every other day for 21 days using a whole-body counter. Liver manganese was higher (P less than 0.0001) in soy protein-fed rats (8.8 micrograms/g) than in casein-fed rats (5.2 micrograms/g); manganese superoxide dismutase activity also was higher in soy protein-fed rats than in casein-fed rats (P less than 0.01). There was a significant interaction between manganese and protein which affected manganese absorption and biologic half-life of 54Mn. In a second experiment, rats fed soy protein-test meals retained more 54Mn (P less than 0.001) than casein-fed rats. Liver manganese (8.3 micrograms/g) in the soy protein group was also higher than that (5.7 micrograms/g) in the casein group (P less than 0.0001), but manganese superoxide dismutase activity was unaffected by protein. Supplementation with methionine increased 54Mn retention from both soy and casein diets (P less than 0.06); activity of manganese superoxide dismutase increased (P less than 0.05) but liver manganese did not change. The addition of arginine to casein diets had little effect on manganese bioavailability. Phytic acid affected neither manganese absorption nor biologic half-life in two experiments, but it depressed liver manganese in one experiment. These results suggest that neither arginine nor phytic acid was the component in soy protein which made manganese more available from soy protein diets than casein diets.